Quantitative analysis for Corbus Pharmaceuticals Holdings, Inc. (CRBP) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Strong Buy (74.0) (grade A). 28 signals analyzed (23 differentiated alt-data).
CRBP stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $10.29 | $9.70 | $9.82 |
| 2026-05-08 | $11.28 | $10.79 | $10.96 |
| 2026-05-20 | $9.87 | $9.22 | $9.73 |
| 2026-06-02 | $7.68 | $7.12 | $7.54 |
| 2026-06-12 | $8.32 | $7.74 | $8.19 |
| 2026-06-25 | $8.53 | $8.10 | $8.25 |
| 2026-07-08 | $9.65 | $9.19 | $9.55 |
| 2026-07-20 | $9.22 | $8.85 | $8.89 |
| 2026-07-30 | $9.36 | $8.79 | $9.05 |
| 2026-08-12 | $9.91 | $9.40 | $9.76 |
| 2026-08-24 | $10.87 | $9.68 | $10.69 |
| 2026-09-03 | $11.60 | $11.22 | $11.46 |
How Corbus Pharmaceuticals Holdings, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| HYPR | Hyperfine, Inc. | $124M | — |
| PYXS | Pyxis Oncology, Inc. | $127M | 43.0 |
| FONR | FONAR Corporation | $117M | — |
| MIST | Milestone Pharmaceuticals Inc. | $129M | — |
View all Health Care stocks by valuation and signals →
Corbus Pharmaceuticals Holdings, Inc. (CRBP) scores Strong Buy (74.0), with no measured dimension below 92. Its highest are technicals at 98, analyst consensus at 94, competitive moat at 92, across 3 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 98 |
| analyst consensus | 94 |
| competitive moat | 92 |
StoQuant analyzes 28 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Corbus Pharmaceuticals Holdings, Inc. (CRBP): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/CRBP"><img src="https://stoquant.com/badge/CRBP.svg" alt="Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.